Anthony Mack

2021

In 2021, Anthony Mack earned a total compensation of $758K as Chief Executive Officer at Virpax Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Bonus$225,000
Option Awards$158,000
Salary$375,000
Total$758,000

Mack received $375K in salary, accounting for 49% of the total pay in 2021.

Mack also received $225K in bonus and $158K in option awards.

Rankings

In 2021, Anthony Mack's compensation ranked 9,653rd out of 12,415 executives tracked by ExecPay. In other words, Mack earned more than 22.2% of executives.

ClassificationRankingPercentile
All
9,653
out of 12,415
22nd
Division
Manufacturing
4,276
out of 5,505
22nd
Major group
Chemicals And Allied Products
1,893
out of 2,375
20th
Industry group
Drugs
1,679
out of 2,096
20th
Industry
Pharmaceutical Preparations
1,249
out of 1,546
19th
Source: SEC filing on June 15, 2022.

Mack's colleagues

We found two more compensation records of executives who worked with Anthony Mack at Virpax Pharmaceuticals in 2021.

2021

Christopher Chipman

Virpax Pharmaceuticals

Chief Financial Officer

2021

Jeffrey Gudin

Virpax Pharmaceuticals

Chief Medical Officer

News

You may also like